Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

7.7%

3 terminated/withdrawn out of 39 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

21%

8 trials in Phase 3/4

Results Transparency

22%

4 of 18 completed trials have results

Key Signals

7 recruiting4 with results

Enrollment Performance

Analytics

Phase 2

9(32.1%)

Phase 4

7(25.0%)

N/A

6(21.4%)

Phase 1

5(17.9%)

Phase 3

1(3.6%)

28Total

Phase 2(9)

Phase 4(7)

N/A(6)

Phase 1(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (39)

Showing 20 of 39 trials

NCT07552922Not ApplicableRecruiting

Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

Role: lead

NCT04925648Phase 2Completed

Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction

Role: lead

NCT07203391Phase 1Recruiting

Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis

Role: lead

NCT03522064Phase 2Recruiting

Bipolar Androgen Therapy + Carboplatin in mCRPC

Role: lead

NCT05187884Phase 2Completed

Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma

Role: lead

NCT05898776Not ApplicableActive Not Recruiting

10°C vs 4°C Lung Preservation RCT

Role: collaborator

NCT05154162Phase 3Active Not Recruiting

PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI

Role: collaborator

NCT07063875Phase 1Recruiting

Adding IL-2 to Tebentafusp to Eradicate Cancer Progression

Role: lead

NCT05156892Phase 1Active Not Recruiting

Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer

Role: collaborator

NCT04947189Phase 1Recruiting

Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer

Role: lead

NCT06907641Phase 2Recruiting

Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy

Role: lead

NCT04586855Completed

Ultrasound Imaging of the Larynx and Diaphragm During NIV and Cough Assist

Role: collaborator

NCT01120795Phase 4Completed

Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy

Role: collaborator

NCT03513211Phase 1Completed

Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer

Role: lead

NCT05613842Phase 2Completed

Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP)

Role: lead

NCT03793257Recruiting

The EXCEL Registry of Patients Requiring ECMO

Role: collaborator

NCT02881814Not ApplicableUnknown

UltraSound for Accurate Decisions in Chest PhysioTherapy

Role: collaborator

NCT05889728Phase 2Unknown

Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer

Role: lead

NCT03714048Completed

Blood Management During ECMO for Cardiac Support

Role: lead

NCT04268342Not ApplicableUnknown

Gonorrhoea Resistance Assessment by Nucleic Acid Detection (GRANDII)

Role: collaborator